ArticleJCI insight2023
Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model.
Matthew A Ingersoll et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papertrialcites it